Market Tracker

06/22 7:49am ET

ImmunoGen Inc (NASDAQ:IMGN)

6.02
Delayed Data
As of Jun 21
 +0.60 / +11.07%
Today’s Change
1.51
Today|||52-Week Range
6.10
+195.10%
Year-to-Date
ImmunoGen (IMGN) Jumps: Stock Rises 10.4%
Jun 21 / Zacks.com - Paid Partner Content
Why Is ImmunoGen (IMGN) Stock Up 131% This Year?
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.42
Today’s open5.48
Day’s range5.48 - 6.10
Volume6,392,592
Average volume (3 months)2,337,536
Market cap$537.9M
Dividend yield--
Data as of 06/21/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+13.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...+1.29+9.45%
ANIPANI Pharmaceuticals ...+0.65+1.42%
AUPHAurinia Pharmaceutic...-0.23-3.42%
RXDXIgnyta Inc+0.25+2.56%
Data as of 06/21/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts